What are the NICE guidelines for induction of labour?

NICE Guidelines for Induction of Labour

I must clarify that the evidence provided does not contain actual NICE guidelines—the studies presented are primarily AAFP and ACOG guidelines from 2000-2015, with research on guideline implementation and methods. However, I can synthesize what is known about induction of labour based on the available guideline evidence, noting where NICE-specific recommendations are referenced.

Key Pharmacological Methods

Prostaglandins for Cervical Ripening

Vaginal misoprostol (≤50 μg) represents the most effective method for achieving vaginal delivery within 24 hours 1. The evidence demonstrates:

• Lower doses (25 μg every 3-6 hours) are effective and safer for cervical ripening and labor induction 2
• Higher doses (50 μg every 6 hours) may be appropriate in select situations but carry increased risk of uterine hyperstimulation 2
• Misoprostol should NEVER be used in women with previous cesarean delivery due to 13% uterine rupture risk 3, 2

PGE2 (Dinoprostone)

• Both vaginal gel and controlled-release pessaries are effective
• Continuous fetal monitoring required from placement until 15 minutes after removal of vaginal inserts 2
• Monitoring for 30 minutes to 2 hours after gel administration 2
• Uterine rupture risk in women with prior cesarean: 2% (95% CI 1.1-3.5%) 3

Oxytocin

• Either low-dose or high-dose oxytocin regimens are appropriate when induction is indicated 2
• More effective when combined with amniotomy (Oxytocin+Amniotomy) 1
• Uterine rupture risk in women with prior cesarean: 1.1% (95% CI 0.9-1.5%) 3
• Less effective than prostaglandins when cervix is unfavorable 4

Mechanical Methods

Balloon catheters (single or double) are safe alternatives, particularly in high-risk situations:

• No reported uterine ruptures with Foley catheter use 3
• Probably reduce uterine hyperstimulation compared to vaginal misoprostol (RR 0.38,95% CI 0.21-0.69) 1
• Combining balloon catheter with misoprostol or oxytocin enhances efficacy 4
• Preferred in women with cardiovascular disease where hemodynamic changes are detrimental 5

Critical Safety Considerations

Uterine Hyperstimulation Risk (Ranked Best to Worst)

1. Nitric oxide donors (RR 0.05 vs vaginal misoprostol) 1
2. Osmotic cervical dilators (RR 0.07) 1
3. Balloon catheters (RR 0.38) 1
4. Oral misoprostol ≤50 μg (RR 0.62) 1
5. Vaginal misoprostol (reference)

Absolute Contraindications

• Misoprostol in third trimester with previous cesarean delivery (13% rupture rate) 3, 2
• Dinoprostone in active cardiovascular disease (profound BP effects) 5

Timing and Patient Selection

Spontaneous vs Induced Labour

Spontaneous onset of labour is preferable for the majority of women with normal cardiac function 5. For low-risk nulliparous women:

• Elective induction at 39 weeks reduces cesarean delivery rates compared to expectant management 6
• Timing should be individualized based on Bishop score, fetal well-being, and maternal cardiac status 5

Favorable vs Unfavorable Cervix

• Oxytocin and artificial rupture of membranes indicated when Bishop score is favorable 5
• Avoid prolonged induction when cervix is unfavorable 5
• Cervical ripening agents required for modified Bishop score <5 6

Monitoring Requirements

All induction methods require specific monitoring protocols:

• PGE2 vaginal insert: continuous monitoring from placement until 15+ minutes after removal 2
• PGE2 gel: continuous monitoring for 30 minutes to 2 hours post-administration 2
• Allow at least 12 hours after cervical ripening completion before considering cesarean for "failed" induction in latent phase 6

Special Populations

Women with Previous Cesarean (VBAC)

• Labor induction is suitable when indicated, but method selection is critical 3
• Oxytocin: acceptable (1.1% rupture risk)
• PGE2: higher risk (2% rupture risk)
• Misoprostol: absolutely contraindicated (13% rupture risk)
• Foley catheter: safest option (no reported ruptures)

Intrauterine Fetal Death

• Mifepristone 200 mg followed by misoprostol significantly reduces induction-to-delivery interval (9.8 vs 16.3 hours) 7
• High-dose PGE2 vaginal suppositories effective for second-trimester management 2
• Intravaginal misoprostol can be used for third-trimester fetal demise 2

Common Pitfalls

1. Using misoprostol in women with scarred uterus—this is the single most dangerous error
2. Inadequate monitoring duration after prostaglandin administration
3. Premature cesarean delivery before allowing adequate time for cervical ripening and latent phase
4. Using dinoprostone in women with cardiovascular disease
5. Exceeding recommended maximum prostaglandin doses (86.4% of UK units exceeded NICE recommendations for tablets) 8

The evidence shows substantial variation exists between international guidelines 9, 10, but the safety principles regarding misoprostol contraindications and monitoring requirements remain consistent across all major societies.